Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
Neural Regulation01:37

Neural Regulation

42.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

763
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
763
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transparent polypyrrole-nanocellulose hydrogel electrodes with durable skin adhesion for wearable ECG monitoring.

Journal of colloid and interface science·2026
Same author

Overweight/obesity and gait abnormality: what role does the brain play in the relationship?

International journal of obesity (2005)·2026
Same author

Age-related metabolomic signatures and stroke susceptibility in a population-based cohort.

GeroScience·2026
Same author

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Brain : a journal of neurology·2026
Same author

Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China.

Neurology·2026
Same author

Endothelial FAM171A2 is required for maintaining autophagy flux and blood-brain barrier integrity.

Science bulletin·2026

Related Experiment Video

Updated: Nov 24, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.4K

Exosomes in Parkinson disease.

Jennifer R Pinnell1,2, Mei Cui3, Kim Tieu1,4

  • 1Department of Environmental Health Sciences, Florida International University, Miami, FL, USA.

Journal of Neurochemistry
|December 29, 2020
PubMed
Summary

Extracellular vesicles called exosomes may spread Parkinson disease (PD) pathology via alpha-synuclein. Exosomes also show promise as biomarkers and therapeutic delivery vectors for PD.

Keywords:
Parkinson diseasealpha-synucleinexosomesextracellular vesiclesneurodegenerationprotein aggregation

More Related Videos

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
07:55

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

665
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.4K

Related Experiment Videos

Last Updated: Nov 24, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

Published on: April 4, 2022

3.4K
Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
07:55

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

665
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.4K

Area of Science:

  • Neurodegenerative diseases
  • Cell biology
  • Biochemistry

Background:

  • Parkinson disease (PD) is characterized by misfolded alpha-synuclein aggregates.
  • Exosomes, a type of extracellular vesicle, are increasingly recognized for their role in intercellular communication.
  • Exosomes can transport proteins and genetic material, potentially mediating the spread of PD pathology.

Purpose of the Study:

  • To review the current understanding of exosome involvement in Parkinson disease.
  • To explore the potential clinical applications of exosomes in PD diagnosis and treatment.

Main Methods:

  • Literature review of recent studies on exosomes and Parkinson disease.
  • Analysis of exosome composition and function in the context of PD neuropathology.
  • Evaluation of exosome-based diagnostic and therapeutic strategies for PD.

Main Results:

  • Exosomes facilitate the propagation of pathological alpha-synuclein and related genetic materials (mRNA, microRNAs) in PD.
  • Exosome detection in extracellular fluids presents potential for PD biomarker development.
  • The small size and cargo capacity of exosomes suggest their utility as therapeutic delivery vectors.

Conclusions:

  • Exosomes play a significant role in the progression of Parkinson disease pathology.
  • Exosomes offer promising avenues for developing novel biomarkers and therapeutic interventions for PD.